[1] |
WANG Juan, LIU Weiying, YE Yucai, FU Wenli, ZHANG Sha, LI Leping.
Research progress of norepinephrine reuptake inhibitor combined with antimuscarinic in the treatment of obstructive sleep apnea
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 714-720.
|
[2] |
YI Shenghua, LI Yuhong, ZHENG Xiaozhu, AN Manli, DING Qiannan, RU Guomei, ZHANG Lin.
Effects of vasoactive drugs on crystalloid fluid kinetics in septic sheep
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(10): 1081-1089.
|
[3] |
YU Li-zhen, BIAN Hui-ming , YU Jing-hua.
Effects of Liuweidihuang Formula (LWDHF) on ET,TXA2,PGI2 and protecting the endotheliocytes in the blood plasma of rats with hyperlipidemia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(5): 503-506.
|
[4] |
LONG Xiao-li, ZHANG Yao-heng, LU Wei-qin, LING Ze-yi.
Effects of norepinephrine on proliferation, migration and invasion of human lung carcinoma cell line H460
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(11): 1217-1221.
|
[5] |
LI Pei-wu, WANG Xian-kun, CHONG Xiao-qin, LI Pei-jie, CUI Hong-bin, LU Yan, FU Zhong-xue.
Cardiovascular responses evoked by endothelin-1(1-31) microinjected into the nucleus tractus solitarius
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(7): 754-759.
|
[6] |
YAN Mo-lei, YAN Jing, YU Yi-hua, CHEN Jin, CAI Guo-long.
Impact of dopamine and norepinephrine on sublingual microcirculation of the septic shock
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(5): 565-569.
|
[7] |
LV Gan-xin, ZHANG Teng, ZHOU Na-dan, CHEN Yi-he, GE Li-Sha, LI Yue-chun.
Effects of carvedilol on plasma norepinephrine and myocardial IL-6 production in murine model with the coxsackievirus B3-induced viral myocarditis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(12): 1332-1337.
|
[8] |
CHEN Ai-dong, LI Juan, XIE Hai-tang.
Recent research progress in cardiovascular effects of endothelin
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(8): 937-944.
|
[9] |
FAN Xiao, XU Yang, ZHANG Hong-liang.
Protective effects of Omeprazole on the toxic acute gastric mucosal lesion in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(6): 626-630.
|
[10] |
SUN Yu-ming, LOU Jian-Tao, HUANG Guang-xiang, SUN Jun.
Study on the therapeutic effects of ferulic acid sodium in cerebral hemorrhage model rats induced by collagenase and its mechanism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(12): 1377-1382.
|
[11] |
MAO Yao-sheng, CAO miao-ying, ZHOU Xin.
Effects of intensive insulin therapy on the prognosis and serum vWF,ET-1 and NO levels in patients with sepsis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(12): 1414-1417.
|
[12] |
XU Jin, DAI De-zai, PENG Hong-jun, DAI Yin.
Stress induced early renal injury by upregulating NADPH oxidase, hyperphosphorylation of PKCε is mitigated by endothelin receptor antagonist CPU0213
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(11): 1247-1252.
|
[13] |
PENG Hong-jun, JI Hui, DAI De-zai, DAI Yin.
Protective effects of cyclosporine A on myocardial damage and fibrosis induced by isoproterenol via ET pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(9): 966-971.
|
[14] |
XU Hai-hong, YANG Li-cai, YANG Yan-lang, ZHANG Dao-you.
Valsartan decrease expression of endothelin-1 in myocardium of rats with chronic renal failure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(6): 639-643.
|
[15] |
AN Na-qin, DING Xuan-sheng.
Mechanisms and changes of endogenous vasoconstrictive substances in development of diabetic nephropathy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(5): 589-595.
|